- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT01708343
Paraspinal Stimulation in Treating MPS (DIMMST)
Paraspinal Stimulation Combined With Trigger Point Needling and Needle Rotation in Treating Myofascial Pain: Randomized Sham-controlled Clinical Trial
Studienübersicht
Studientyp
Einschreibung (Voraussichtlich)
Phase
- Phase 3
Kontakte und Standorte
Studienorte
-
-
RS
-
Porto Alegre, RS, Brasilien, 90035-003
- Rekrutierung
- Hospital de Clinicas de Porto Alegre
-
Kontakt:
- José R Goldim, PhD
- Telefonnummer: 55 (51) 3359-8856
- E-Mail: jrgoldim@gmail.com
-
Hauptermittler:
- Wolnei Caumo, MD., PhD
-
Unterermittler:
- IRACI LS TORRES, PhD
-
Unterermittler:
- FELIPE GREGNI, PhD
-
Porto Alegre, RS, Brasilien, 90035-003
- Rekrutierung
- Hospital de Clínicas E Porto Alegre
-
Kontakt:
- JOSE GOLDIM, PhD
- Telefonnummer: 55 (51) 3359-8856.
- E-Mail: jrgoldim@gmail.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion criteria
- Myofascial pain syndrome (MPS) (defined as regional pain, normal neurologic examination, presence of TrPs, taut bands, tender points, and pain characterized as "dull," "achy," or "deep" were relevant to MPS diagnosis. Additionally, palpable nodules, pain that is exacerbated by stress, decreased range of motion, and ropiness in the muscle).
- Disability in the last three months: (defined if they had one or more these limitation in active and routine activities by MPS : (i) interference with work, (ii) enjoyable activities, (iii) responsibilities at home, (iv) relationships, (v) personal goals, (vi) thinking clearly, and problem solving, concentrating, or remembering during the last three months).
- Women
- Age: 19 to 50 years
Exclusion criteria
Rheumatoid arthritis
Fibromyalgia
Previous surgery on the affected areas
Prior experience with acupuncture
Primary radiculopathy
Current use of psychotropic drugs (ilicits
) Habitual use of anti-inflammatory steroids.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
---|---|
Schein-Komparator: Placebo-sham
Placebo-sham twice a week during four weeks
|
Andere Namen:
|
Aktiver Komparator: Lidocaine injection
Lidocaine 0.2-0.5 mL of 1% injected each time into the trigger point.
Twice a week during four weeks
|
Andere Namen:
|
Experimental: DIMMST
DIMMST include the combination of trigger point deep dry needling (TrP-DDN) is combined with paraspinal deep intramuscular stimulation (PDIMS) and needle rotation (NR). Twice a week during four weeks |
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Pain severity
Zeitfenster: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
a) The intensity of pain was measured by a 10-cm VAS [30].
VAS scores ranged from no pain (zero) to the worst possible pain (10 cm).
|
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Pain threshold
Zeitfenster: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Pain pressure threshold (PPT)
|
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Sleep quality - how did you feel when you woke up
Zeitfenster: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS: In general, how did you feel when you woke up? |
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality - compared to your habitual sleep
Zeitfenster: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS: Assess the sleep quality of the previous night compared to your habitual sleep? |
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality -last night
Zeitfenster: A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Sleep quality was recorded daily by the 10-cm visual analog sleep quality scale (VASQS) in the sleep diary using VASQS: How well did you sleep last night? |
A cumulative mean of each week during the treatmetn period (four weeks - the pain diary begin in the first of treatment to the last session)
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
---|---|---|
Physical and mental Health
Zeitfenster: Before to begin treatment and after end treatment
|
Health-related quality of life, assessed at baseline and the end of treatment sessions, was measured with the SF-12 Summary Scales
|
Before to begin treatment and after end treatment
|
Mitarbeiter und Ermittler
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Voraussichtlich)
Studienabschluss (Voraussichtlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- MPS-DIMS
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Clinical Study - RCT
-
University of VermontUniversity of Vermont Medical CenterAbgeschlossenHautkrankheiten | Entscheidungsunterstützungssysteme, Clinical
-
Hao LiuAbgeschlossenChronische Venenerkrankung (CVD), Venencompliance, Venous Clinical Severity Score (VCSS)China
-
Abramson Cancer Center of the University of PennsylvaniaZurückgezogenKrebspatienten, die sich einer Stammzelltransplantation unterziehen (RCT von ACP zur Transplantation)
-
OrthoSpace Ltd.BeendetMassive RCT (MRCT) in voller Dicke mit einem Durchmesser von mindestens 5 cm, einschließlich Fettinfiltration Grad III oder IVItalien
-
Hospices Civils de LyonRekrutierungKlinische Demenzbewertung (CDR) aus der Analyse der Krankenakte | Clinical Dementia Rating (CDR) Persönliches Interview mit dem PatientenFrankreich